ENTEROSYS - Gut Is The Link
Entity

  • ENTEROSYS - Gut Is The Link

    Created in 2017
  • BETA

    Up & running (A)
    Existing signals show a regular activity

  • Social networks

    3,206

  • Activities

    deeptech biotech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    57 Rue de l'Innovation, 31670 Labège, France

    Labège

    France

  • Employees

    Scale: 2-10

    Estimated: 9

  • Engaged corporates

    0
    0 0

  • Added in Motherbase

    9 months ago
Description
  • Value proposition

    Preclinical studies in gut and gut brain for therapies of tomorrow

    ENTEROSYS is specialised in the preclinical evaluation of compounds of interest on the digestive sphere, the enteric nervous system and the communication between the gut and peripheral organs. Thanks to innovative state-of-the-art techniques based on the analysis of physiological parameters in real time, our expertise allows us to develop proofs of concept and to study precisely the mechanisms of action of molecules of therapeutic interest (i.e. drug candidates, dietary supplements, etc.) to prevent risk factors or to treat pathologies where the communication between the intestinal tract and the other organs is altered, such as neurodegenerative diseases and metabolic diseases in particular, but not only.


    Type 2 diabetes, Gut-Brain axis, Enteric nervous system targetting, Preclinical studies, Metabolic diseases , Body weight control, Gut-organs axis, Neurodegenerative diseases, Dermatological diseases, and Gastrointestinal diseases

  • Original language

    Preclinical studies in gut and gut brain for therapies of tomorrow

    ENTEROSYS is specialised in the preclinical evaluation of compounds of interest on the digestive sphere, the enteric nervous system and the communication between the gut and peripheral organs. Thanks to innovative state-of-the-art techniques based on the analysis of physiological parameters in real time, our expertise allows us to develop proofs of concept and to study precisely the mechanisms of action of molecules of therapeutic interest (i.e. drug candidates, dietary supplements, etc.) to prevent risk factors or to treat pathologies where the communication between the intestinal tract and the other organs is altered, such as neurodegenerative diseases and metabolic diseases in particular, but not only.

  • CRO for preclinical studies rooted in gut & gut-brain axis

    Thanks to our cutting-edge expertise focused on the gut and inter-organ communication, our CRO enables you to make major scientific advances

    • https://www.enterosys.com/
Corporate interactions BETA
Corporate TypeTweets Articles
No interactions
Similar entities
Last news
Show all articles
Social network dynamics